Poster Presenter

Hybrid Nanoparticles Targeted By Antitumor Antibodies And Emitting Alpha-Particles
D.Y. Chuvilin and V.A. Zagryadskiy
Russia

Here we describe a new therapeutic nanoparticle’s design, which consists of three parts: targeting, effecter and linker. Targeted radionuclide therapy with the use of alpha-emitting radionuclides is currently one of the most promising and rapidly expanding methods for treating oncology diseases. The alpha-emitters are applied for labeling the monoclonal antibodies, synthetic polypeptides, albumin micro spheres etc. Such complexes provide alpha-emitter delivery to the certain cancerous cell.